ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Editorial: Ambiance Through Exclusion

May 20, 1994

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012